Digital Solutions for bEtter cAre

European Institute of Oncology200 enrolled

Overview

The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

200

Conditions

Cancer Diagnosis

Interventions

Patients, survivors, caregivers, family members and healthcare professionalsBEHAVIORAL

Focus group discussions (FGD) and completion of survey

Eligibility

Sex: ALLMin age: 12 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: HEALTHCARE PROFESSIONALS: * Healthcare professionals actually working in oncology and/or psychooncology; * Teachers of paediatric cancer patients. ADULT POPULATION: * Patients with a current or previous cancer diagnosis * Adequate language proficiency, * Able to provide informed consent; PAEDIATRIC POPULATION: * Older than 12 years of age; * Patients with a current or previous cancer diagnosis; * Adequate language proficiency; * Legal guardians of paediatric cancer patients able to provide informed consent. CAREGIVERS: * Caregivers and/or family members of cancer patients who lived or assist the loved ones with a current or previous cancer diagnosis in the cancer journey; * Adequate language proficiency; * Able to provide informed consent; * Caregivers and/or family members of paediatric cancer patients under 12 years of age. Exclusion Criteria: * Healthcare professionals with limited oncology patient contact; * Insufficient knowledge of the local language; * Severe cognitive impairment, and/or mental disorders that prohibited their participation in the study or inadequate verbal skills that may render them incapable of informed consent (as evaluated by the clinician); * Inability to understand the study materials (as evaluated by the clinician); * Physical or psychological impairment that prohibits their participation in focus groups (as evaluated by the clinician).

Locations (5)

Centre François Baclesse

Caen, France

RECRUITING

Saarland University

Homburg, Germany

NOT_YET_RECRUITING

European Institute of Oncology

Milan, Italy, Italy

NOT_YET_RECRUITING

Outcomes

Primary Outcomes

Number of unmet needs of patients, caregivers and Health Care Professionals (HCPs)

Number of unmet needs reported by patients, caregivers and Health Care Professionals (HCPs)

Time frame: 15 months

Central Contacts

Gabriella Pravettoni, MD

CONTACT

+390257489731 gabriella.pravettoni@ieo.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.